Dexmedetomidine in Spinal Anesthesia

• Status: Completed
• Trial end date: 2015-07-01
• Target enrollment: 0
• Participant gender: All

Summary

Patients were randomized into two groups, A group and B group. A group and B group patients are injected intravenous dexmedetomidine after intrathecal injection (IT) of heavy bupivacaine and injected intravenous dexmedetomidine before IT of heavy bupivacaine, respectively.

The investigators will compare of hemodynamics and patient's comfortability between two groups.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Inje University
• Treatments: Anesthetics; Bupivacaine; Dexmedetomidine

Criteria

Inclusion Criteria:

• 20 - 60 aged patients

• orthopedic operation undergoing spinal anesthesia

Exclusion Criteria:

• more than American society of anesthesiologists classification 3

• hypertension

• diabetes mellitus

• heart disease (bradycardia, atrioventricular block)